The TCM Preparation Feilike Mixture for the Treatment of Pneumonia: Network Analysis, Pharmacological Assessment and Silico Simulation

The Feilike mixture (FLKM) is a valid prescription that is frequently used to assist in the clinical treatment of pneumonia. However, the mechanisms of its effects remain unclear. First, through literature evaluation, it was preliminarily determined that FLKM improved clinical symptoms, regulated im...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Juqin, Chen, Xiaoxiao, Hou, Min, Yang, Kuo, Yang, Bing, Wang, Pan, Du, Yang, Yu, Qingyuan, Ren, Junguo, Liu, Jianxun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918795/
https://www.ncbi.nlm.nih.gov/pubmed/35295341
http://dx.doi.org/10.3389/fphar.2022.794405
_version_ 1784668807374045184
author Peng, Juqin
Chen, Xiaoxiao
Hou, Min
Yang, Kuo
Yang, Bing
Wang, Pan
Du, Yang
Yu, Qingyuan
Ren, Junguo
Liu, Jianxun
author_facet Peng, Juqin
Chen, Xiaoxiao
Hou, Min
Yang, Kuo
Yang, Bing
Wang, Pan
Du, Yang
Yu, Qingyuan
Ren, Junguo
Liu, Jianxun
author_sort Peng, Juqin
collection PubMed
description The Feilike mixture (FLKM) is a valid prescription that is frequently used to assist in the clinical treatment of pneumonia. However, the mechanisms of its effects remain unclear. First, through literature evaluation, it was preliminarily determined that FLKM improved clinical symptoms, regulated immune inflammation response and ameliorated pulmonary function. Then, via database search and literature mining, 759 targets of the 104 active compounds of FLKM were identified. The component-target (CT) network showed that the key active compositions were resveratrol, stigmasterol, beta-sitosterol, sesamin, and quercetin. 115 targets overlapped with pneumonia-related targets. The protein-protein interaction (PPI) network identified TNF, AKT1, IL6, JUN, VEGFA and MAPK3 as hub targets. KEGG analyses found that they were mainly enriched in immune related pathway. Next, in vivo experiment, we observed that FLKM ameliorated pathological injury of lung tissue and reduced neutrophil infiltration in rats with LPS-induced pneumonia. And FLKM decreased the concentration of TNF-α and IL-6 in BALF and downregulated the expression of p38MAPK, AKT and VEGFA in lung tissue. Finally, Molecular docking tests showed tight docking of these predicted targeted proteins with key active compounds. Molecular dynamics simulation was employed to assess stability and flexibility of receptor-ligand. Among them, AKT1- stigmasterol bound more stably, and their binding free energies were −47.91 ± 1.62 kcal/mol. This study revealed core compositions and targets for FLKM treating pneumonia and provided integrated pharmacological evidence to support its clinical efficacy.
format Online
Article
Text
id pubmed-8918795
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89187952022-03-15 The TCM Preparation Feilike Mixture for the Treatment of Pneumonia: Network Analysis, Pharmacological Assessment and Silico Simulation Peng, Juqin Chen, Xiaoxiao Hou, Min Yang, Kuo Yang, Bing Wang, Pan Du, Yang Yu, Qingyuan Ren, Junguo Liu, Jianxun Front Pharmacol Pharmacology The Feilike mixture (FLKM) is a valid prescription that is frequently used to assist in the clinical treatment of pneumonia. However, the mechanisms of its effects remain unclear. First, through literature evaluation, it was preliminarily determined that FLKM improved clinical symptoms, regulated immune inflammation response and ameliorated pulmonary function. Then, via database search and literature mining, 759 targets of the 104 active compounds of FLKM were identified. The component-target (CT) network showed that the key active compositions were resveratrol, stigmasterol, beta-sitosterol, sesamin, and quercetin. 115 targets overlapped with pneumonia-related targets. The protein-protein interaction (PPI) network identified TNF, AKT1, IL6, JUN, VEGFA and MAPK3 as hub targets. KEGG analyses found that they were mainly enriched in immune related pathway. Next, in vivo experiment, we observed that FLKM ameliorated pathological injury of lung tissue and reduced neutrophil infiltration in rats with LPS-induced pneumonia. And FLKM decreased the concentration of TNF-α and IL-6 in BALF and downregulated the expression of p38MAPK, AKT and VEGFA in lung tissue. Finally, Molecular docking tests showed tight docking of these predicted targeted proteins with key active compounds. Molecular dynamics simulation was employed to assess stability and flexibility of receptor-ligand. Among them, AKT1- stigmasterol bound more stably, and their binding free energies were −47.91 ± 1.62 kcal/mol. This study revealed core compositions and targets for FLKM treating pneumonia and provided integrated pharmacological evidence to support its clinical efficacy. Frontiers Media S.A. 2022-02-28 /pmc/articles/PMC8918795/ /pubmed/35295341 http://dx.doi.org/10.3389/fphar.2022.794405 Text en Copyright © 2022 Peng, Chen, Hou, Yang, Yang, Wang, Du, Yu, Ren and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Peng, Juqin
Chen, Xiaoxiao
Hou, Min
Yang, Kuo
Yang, Bing
Wang, Pan
Du, Yang
Yu, Qingyuan
Ren, Junguo
Liu, Jianxun
The TCM Preparation Feilike Mixture for the Treatment of Pneumonia: Network Analysis, Pharmacological Assessment and Silico Simulation
title The TCM Preparation Feilike Mixture for the Treatment of Pneumonia: Network Analysis, Pharmacological Assessment and Silico Simulation
title_full The TCM Preparation Feilike Mixture for the Treatment of Pneumonia: Network Analysis, Pharmacological Assessment and Silico Simulation
title_fullStr The TCM Preparation Feilike Mixture for the Treatment of Pneumonia: Network Analysis, Pharmacological Assessment and Silico Simulation
title_full_unstemmed The TCM Preparation Feilike Mixture for the Treatment of Pneumonia: Network Analysis, Pharmacological Assessment and Silico Simulation
title_short The TCM Preparation Feilike Mixture for the Treatment of Pneumonia: Network Analysis, Pharmacological Assessment and Silico Simulation
title_sort tcm preparation feilike mixture for the treatment of pneumonia: network analysis, pharmacological assessment and silico simulation
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918795/
https://www.ncbi.nlm.nih.gov/pubmed/35295341
http://dx.doi.org/10.3389/fphar.2022.794405
work_keys_str_mv AT pengjuqin thetcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation
AT chenxiaoxiao thetcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation
AT houmin thetcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation
AT yangkuo thetcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation
AT yangbing thetcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation
AT wangpan thetcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation
AT duyang thetcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation
AT yuqingyuan thetcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation
AT renjunguo thetcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation
AT liujianxun thetcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation
AT pengjuqin tcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation
AT chenxiaoxiao tcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation
AT houmin tcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation
AT yangkuo tcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation
AT yangbing tcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation
AT wangpan tcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation
AT duyang tcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation
AT yuqingyuan tcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation
AT renjunguo tcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation
AT liujianxun tcmpreparationfeilikemixtureforthetreatmentofpneumonianetworkanalysispharmacologicalassessmentandsilicosimulation